Osteoclastic resorptive capacity is suppressed in patients receiving hyperbaric oxygen therapy

BACKGROUND AND PURPOSE: Hypoxia, necrosis, and bone loss are hallmarks of many skeletal diseases. Hyperbaric oxygen therapy (HBO) is often used as an adjunctive therapy in these cases. However the in vivo effect of HBO on osteoclast formation has not been fully established. We therefore carried out...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadi, Hadil Al, Smerdon, Gary, W Fox, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2015
Materias:
Miscellaneous
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404782/
https://www.ncbi.nlm.nih.gov/pubmed/25238438
http://dx.doi.org/10.3109/17453674.2014.964621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404782/
https://www.ncbi.nlm.nih.gov/pubmed/25238438
http://dx.doi.org/10.3109/17453674.2014.964621

Ejemplares similares